Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/29346
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Coleções
- INI - Artigos de Periódicos [3488]
Metadata
Mostrar registro completo
HEALTH OUTCOMES AMONG HIV-POSITIVE LATINOS INITIATING ANTIRETROVIRAL THERAPY IN NORTH AMERICA VERSUS CENTRAL AND SOUTH AMERICA
Antiretroviral therapy
Highly active
Mortality
Latin America
North America
Cohort studies
Autor(es)
Cesar, Carina
Koethe, John R.
Giganti, Mark J.
Rebeiro, Peter
Althoff, Keri N.
Napravnik, Sonia
Mayor, Angel
Grinsztejn, Beatriz
Wolff, Marcelo
Padgett, Denis
Sierra-Madero, Juan
Gotuzzo, Eduardo
Sterling, Timothy R.
Willig, James
Levison, Julie
Kitahata, Mari
Rodriguez-Barradas, Maria C.
Moore, Richard D.
McGowan, Catherine
Shepherd, Bryan E.
Cahn, Pedro
CCASAnet
NA-ACCORD
Koethe, John R.
Giganti, Mark J.
Rebeiro, Peter
Althoff, Keri N.
Napravnik, Sonia
Mayor, Angel
Grinsztejn, Beatriz
Wolff, Marcelo
Padgett, Denis
Sierra-Madero, Juan
Gotuzzo, Eduardo
Sterling, Timothy R.
Willig, James
Levison, Julie
Kitahata, Mari
Rodriguez-Barradas, Maria C.
Moore, Richard D.
McGowan, Catherine
Shepherd, Bryan E.
Cahn, Pedro
CCASAnet
NA-ACCORD
Afiliação
Investigaciones Clínicas, Fundación Huésped, Buenos Aires, Argentina.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Department of Internal Medicine, Universidad Central del Caribe, Bayamón, Puerto Rico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundación Arriarán and Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Instituto Hondureño de Seguridad Social and Hospital Escuela Universitario, Tegucigalpa, Honduras.
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
Division of General Internal Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA.
Division of Infectious Diseases, University of Washington, Seattle, WA, USA.
Infectious Diseases Section, Michael E. De Bakey VAMC, Baylor College of Medicine, Houston, TX, USA.
Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Investigaciones Clínicas, Fundación Huésped, Buenos Aires, Argentina.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
Department of Internal Medicine, Universidad Central del Caribe, Bayamón, Puerto Rico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Fundación Arriarán and Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Instituto Hondureño de Seguridad Social and Hospital Escuela Universitario, Tegucigalpa, Honduras.
Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
Instituto de Medicina Tropical Alexander von Humboldt, Lima, Peru.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
Division of General Internal Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, MA, USA.
Division of Infectious Diseases, University of Washington, Seattle, WA, USA.
Infectious Diseases Section, Michael E. De Bakey VAMC, Baylor College of Medicine, Houston, TX, USA.
Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Division of Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN, USA.
Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN, USA.
Investigaciones Clínicas, Fundación Huésped, Buenos Aires, Argentina.
Resumo em Inglês
Latinos living with HIV in the Americas share a common ethnic and cultural heritage. In North America, Latinos have a relatively high rate of new HIV infections but lower rates of engagement at all stages of the care continuum, whereas in Latin America antiretroviral therapy (ART) services continue to expand to meet treatment needs. In this analysis, we compare HIV treatment outcomes between Latinos receiving ART in North America versus Latin America.
Palavras-chave em inglês
HIVAntiretroviral therapy
Highly active
Mortality
Latin America
North America
Cohort studies
Compartilhar